Heart Arrest: Clinical Trials

67 trials for Heart Arrest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed, 9 recruiting, 7 terminated, 5 unknown. 67 Phase 3, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 367Completed 40, Recruiting 9, Terminated 7, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Withdrawn 1
Phase 211Completed 5, Recruiting 4, Not yet recruiting 1, Terminated 1

Follow Heart Arrest: new trials by email Literature Review of Heart Arrest trials Research Report on Heart Arrest

Trials (filtered) newest first · largest first

All 67 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naloxone for In-Hospital Cardiac Arrest
naloxone, Placebo - Heart Arrest
Phase 2 / Phase 3Not yet recruitingRegion Skane8502027-01-012026-09-08
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
Epinephrine 0.5 mg intravenous bolus, Epinephrine 1 mg intravenous bolus - Out-of-hospital Cardiac Arrest (OHCA)
Phase 3Not yet recruitingCentral Hospital, Nancy, France43362026-06-012026-03-02
RECOMMEND Platform Trial
Liberal RBC Transfusion, Restrictive RBC Transfusion - Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome)
Phase 3RecruitingAustralian and New Zealand Intensive Care Research Centre6002026-03-232026-05-13
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
Xenon - Post-Cardiac Arrest Syndrome
Phase 3Not yet recruitingInvero Pharma, Inc.14362026-03-012025-04-03
Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care
Prehospital post cardiac arrest care protocol - Out-of-hospital Cardiac Arrest (OHCA)
Phase 2 / Phase 3RecruitingSiriraj Hospital3182025-12-012026-04-21
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
Amiodarone - Ventricular Arrhythmias and Cardiac Arrest
Phase 3RecruitingVersailles Hospital6742025-11-062025-12-23
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
Double sequential defibirllation, Standard defibrillation - Out of Hospital Cardiac Arrest, Ventricular Fibrillation
Phase 2 / Phase 3RecruitingGabriel Riva9162025-09-082026-02-17
The Application of Positive End-Expiratory Pressure in Out-of-Hospital Cardiac Arrest: The Lazarus-PEEP Trial.
Disposable PEEP Valve set at 5 cm H20., Controle - Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA)
Phase 3RecruitingUniversity Hospital, Ghent1322025-04-252026-01-21
Early Amiodarone in Shockable Cardiac Arrest
Amiodarone Hydrochloride Injection, Usual Care Protocol - Cardiac Arrest
Phase 3RecruitingOregon Health and Science University5852025-01-012025-12-19
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
Phosphocreatine, Placebo - Hypotension, Consciousness, Level Altered
Phase 3RecruitingUniversità Vita-Salute San Raffaele4002024-10-082025-08-06
POHCA Resuscitation: Evaluation of IM Epinephrine
Epinephrine Injection - Pediatric Out-of-Hospital Cardiac Arrest
Phase 2 / Phase 3RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2842024-01-082025-03-11
The Danish Out-of-Hospital Cardiac Arrest Study
Dexamethasone, Backrest elevation, Early wakeup call - Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
Phase 3Active not recruitingChristian Hassager10002023-06-162026-11-05
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
Flecainide, Metoprolol - Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest
Phase 3Active not recruitingOslo University Hospital502023-01-042026-11-03
Surviving PEA in Roanoke (SPEAR) Study
High Calcium, Low Sodium (HCLS) Crystalloid Therapy, High Calcium, High Sodium (HCHS) Crystalloid Therapy - Cardiac Arrest, Pulseless Electrical Activity
Phase 2 / Phase 3RecruitingCarol Bernier3422022-02-162022-03-17
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
Cardiac Sympathetic Denervation (CSD), Routine Care - Sudden Cardiac Death, Ventricular Tachycardia
Phase 3UnknownUniversity of California, Los Angeles402021-07-262024-01-19
Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting
Videolaryngoscopy group, Direct laryngoscopy group - Indication of Orotracheal Intubation, Cardio Respiratory Arrest
Phase 3UnknownAssistance Publique - Hôpitaux de Paris1502021-06-152021-06-18
Preventive VT Substrate Ablation in Ischemic Heart Disease
Ventricular tachycardia substrate-based radiofrequency ablation - Ventricular Tachycardia, Ventricular Arrythmia
Phase 3UnknownCentro Medico Teknon582021-06-012023-08-30
Prophylactic Amiodarone for Shockable Cardiac Arrest
Amiodarone Injection - Cardiac Arrest, Ventricular Arrythmia
Phase 3UnknownWon Young Kim3022021-04-012021-06-21
Micophenolate Mofetil Versus Azathioprine in Myocarditis
mycophenolate mofetil 2 g per day, azathioprine of 150 [75; 150] mg per day - Lymphocytic Myocarditis (Disorder), Heart Failure
Phase 3CompletedI.M. Sechenov First Moscow State Medical University502020-10-012025-07-15
Troriluzole in Adult Participants With Spinocerebellar Ataxia
troriluzole, Placebo - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 3CompletedBiohaven Pharmaceuticals, Inc.2992019-03-082026-11-12

Showing 20 of 67. Sign in to see all of them.

Narrower conditions

Death, Sudden, Cardiac (22)  ·  Arrhythmias, Cardiac (12)  ·  Heart Diseases (12)  ·  Cardiovascular Diseases (11)  ·  Ventricular Fibrillation (11)  ·  Out-of-Hospital Cardiac Arrest (10)  ·  Myocardial Infarction (9)  ·  Tachycardia, Ventricular (6)  ·  Myocardial Ischemia (5)  ·  Coronary Disease (4)  ·  Heart Failure (4)  ·  Hypothermia (4)  ·  Post-Cardiac Arrest Syndrome (3)  ·  Cardiomyopathies (2)

Broader conditions

Cardiovascular Diseases (56)  ·  Heart Diseases (55)  ·  Pathological Conditions, Signs and Symptoms (39)  ·  Pathologic Processes (34)  ·  Death (23)  ·  Death, Sudden (22)  ·  Vascular Diseases (15)  ·  Infarction (9)  ·  Ischemia (9)  ·  Necrosis (9)  ·  Arrhythmias, Cardiac (8)  ·  Cardiac Conduction System Disease (8)  ·  Signs and Symptoms (8)  ·  Nervous System Diseases (6)

Interventions

Amiodarone (7)  ·  Cardiopulmonary Resuscitation (4)  ·  Defibrillators, Implantable (4)  ·  Epinephrine (4)  ·  Sotalol (3)  ·  Arginine Vasopressin (2)  ·  Defibrillators (2)  ·  Flecainide (2)  ·  Hypothermia, Induced (2)  ·  Imipramine (2)  ·  Methylprednisolone (2)  ·  Mexiletine (2)  ·  Procainamide (2)  ·  Quinidine (2)  ·  Vasopressins (2)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (9)  ·  University of Washington (6)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Centre Hospitalier Departemental Vendee (2)  ·  Hospices Civils de Lyon (2)  ·  Ambulance Victoria (1)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Biohaven Pharmaceuticals, Inc. (1)  ·  Boehringer Ingelheim (1)  ·  Brigham and Women's Hospital (1)  ·  Campus Bio-Medico University (1)  ·  Carol Bernier (1)  ·  Central Hospital, Nancy, France (1)  ·  Centro Medico Teknon (1)

Countries

United States (20)  ·  France (14)  ·  Canada (7)  ·  Italy (4)  ·  Spain (4)  ·  Denmark (3)  ·  Norway (3)  ·  Australia (2)  ·  Austria (2)  ·  Belgium (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  China (1)

Top investigators

Alain Cariou, MD, PhD (2)  ·  Alfred Hallstrom (2)  ·  Francis Kim, MD (2)  ·  Jean-Baptiste Lascarrou, MD (2)  ·  Kerry Lee (2)  ·  Akil Awad, M.D. Ph.D. (1)  ·  Alfred P. Hallstrom, PhD (1)  ·  Allan Barker (1)  ·  Andreas Claesson, R.N. Ph.D. (1)  ·  Antonio Berruezo, MD, PhD (1)  ·  Carl Magnusson, R.N., Ph.D. (1)  ·  Carol Bernier, DO (1)  ·  Carol Hodgson, PhD FACP FAHMS (1)

Results publications

PMID 34116828, PMID 15657323, PMID 16772625, PMID 17241734, PMID 17353443, PMID 17823147, PMID 18037223, PMID 18371559, PMID 18381485, PMID 18504334, PMID 19092151, PMID 19451846, PMID 19455024, PMID 19704100, PMID 19854555, PMID 19917887, PMID 20351239, PMID 20362722, PMID 20466215, PMID 20500876, PMID 20818863, PMID 20884379, PMID 20935561, PMID 21879896, PMID 21995804, PMID 22353644, PMID 23280225, PMID 23295834, PMID 23541974, PMID 23842585, PMID 23860985, PMID 24188226, PMID 24240712, PMID 24727258, PMID 25252721, PMID 25268768, PMID 25565457, PMID 25762805, PMID 25913022, PMID 26010524, PMID 26940987, PMID 27043165, PMID 27364049, PMID 27433815, PMID 27482002, PMID 27514751, PMID 27554946, PMID 27562972, PMID 27737774, PMID 27760796

NIH funding

2014 (2), 2009 (1), 2017 (1), 2023 (1), K23HL173647 (1), R01HL031472 (1), R01HL034071 (1), R01HL036821 (1), R01HL089554 (1), R01HL091157 (1), R01HL129722 (1), U01HL045700 (1), U01HL048120 (1), U01HL048159 (1), U01HL055766 (1)